BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15912120)

  • 1. Detection of anti-HLA antibodies with flow cytometry in needle core biopsies of renal transplants recipients with chronic allograft nephropathy.
    Martin L; Guignier F; Bocrie O; D'Athis P; Rageot D; Rifle G; Justrabo E; Mousson C
    Transplantation; 2005 May; 79(10):1459-61. PubMed ID: 15912120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy.
    Martin L; Guignier F; Mousson C; Rageot D; Justrabo E; Rifle G
    Transplantation; 2003 Jul; 76(2):395-400. PubMed ID: 12883199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of donor-specific antibodies in the cortex and the medulla of renal transplants with chronic allograft nephropathy.
    Bocrie O; Hussein Aly AA; Guignier F; Funes de la Vega M; Rifle G; Mousson C; Martin L
    Transpl Immunol; 2007 Apr; 17(3):227-9. PubMed ID: 17331852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of HLA class I- and class II-specific antibodies by flow cytometry and PRA-STAT screening in renal transplant recipients.
    Harmer AW; Heads AJ; Vaughn RW
    Transplantation; 1997 Jun; 63(12):1828-32. PubMed ID: 9210512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
    Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
    Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of enzyme-linked immunoabsorbent assays and flow cytometry techniques for the detection of HLA specific antibodies.
    Worthington JE; Robson AJ; Sheldon S; Langton A; Martin S
    Hum Immunol; 2001 Oct; 62(10):1178-84. PubMed ID: 11600227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
    Süsal C; Opelz G
    Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
    Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
    Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of anti-HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantation.
    Müller-Steinhardt M; Fricke L; Kirchner H; Hoyer J; Klüter H
    Clin Transplant; 2000 Feb; 14(1):85-9. PubMed ID: 10693642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of specificity of anti-human leukocyte antigen antibodies in kidney recipients in reference to clinical outcome.
    Nowosiad-Magda M; Myślak M; Roszkowska P; Borowiec-Chłopek Z; Urasińska E; Różański J; Domański L; Ciechanowski K; Giedrys-Kalemba S
    Transplant Proc; 2014 Oct; 46(8):2606-12. PubMed ID: 25380877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of anti-HLA antibodies eluted from explanted renal allografts.
    Heinemann FM; Roth I; Rebmann V; Arnold ML; Spriewald BM; Grosse-Wilde H
    Clin Transpl; 2006; ():371-8. PubMed ID: 18365391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin isotype-specific characterization of anti-human leukocyte antigen antibodies eluted from explanted renal allografts.
    Heinemann FM; Roth I; Rebmann V; Arnold ML; Witzke O; Wilde B; Spriewald BM; Grosse-Wilde H
    Hum Immunol; 2007 Jun; 68(6):500-6. PubMed ID: 17509449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A significant role for anti-human leukocyte antigen antibodies and antibody-mediated rejection in the biopsy-for-cause population.
    Banasik M; Kościelska-Kasprzak K; Myszka M; Bartoszek D; Zabińska M; Boratyńska M; Kamińska D; Mazanowska O; Zmonarski S; Krajewska M; Hałoń A; Dawiskiba T; Nowakowska B; Klinger M
    Transplant Proc; 2014 Oct; 46(8):2613-7. PubMed ID: 25380878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients.
    Min JW; Lee H; Choi BS; Park CW; Yang CW; Kim YS; Choi YJ; Oh EJ; Chung BH
    Ann Lab Med; 2018 Sep; 38(5):450-457. PubMed ID: 29797816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
    Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure.
    Mizutani K; Terasaki P; Rosen A; Esquenazi V; Miller J; Shih RN; Pei R; Ozawa M; Lee J
    Am J Transplant; 2005 Sep; 5(9):2265-72. PubMed ID: 16095508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.